Core Viewpoint - The company plans to invest in a new biomanufacturing base for APIs and health dietary supplements in collaboration with the local government, aiming to enhance production efficiency and profitability [1] Investment Details - The total investment for the project is 420 million yuan, with approximately 300 million yuan allocated for fixed asset investment [1] - The land for the project will be provided by the local government, and the company will acquire the land use rights through market transactions or leasing [1] Project Construction - The project will involve the construction of production facilities and supporting infrastructure on newly purchased land in the Tokto Economic Development Zone [1] - Upon completion, the project is expected to help the company reduce production costs, expand profit margins, and improve its industrial chain layout [1] Strategic Benefits - The investment is anticipated to enhance the company's core profitability and sustainable development capabilities [1]
拓新药业：子公司拟在内蒙古投资4.2亿元